Every announcement Aurobindo Pharma has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Price
₹1679.8
Market Cap
₹97,563.05 Cr
Revenue TTM
₹34,935.29 Cr
P/E (TTM)
24.76×
Sector 49.41×
Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.
Aurobindo Pharma Secures USFDA Approval for First MDI Product in US$301M Market
Aurobindo Pharma receives USFDA final approval for its first MDI product, targeting a US$301 million market. The approval covers Beclomethasone Inhal…
Aurobindo Pharma Subsidiary Lannett Launches First US Inhalation Product in $908M Market
Aurobindo Pharma subsidiary Lannett launches generic Advair Diskus in the US, marking its first inhalation product entry into the $908M respiratory m…
Track Aurobindo Pharma in real time
ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Aurobindo Pharma files something material.
Start Free — 15-day trial